Past Webinars
Stay up to date on our latest events and webinars.
Tackling Trial Supply Shortages with Advanced IRT
Medication supply shortages have become a widespread industry concern. However, a considered RTSM design can prevent shortages from jeopardizing your study goals.
Topics Covered: IRT
Assessing Prostate Cancer Treatment Response Using PSMA PET/CT
In this webinar, Professor Fendler from the University of Essen and Calyx’s Dr. Oliver Bohnsack will address these challenges and provide recommendations on how to overcome them based on their own lessons learned from conducting prostate cancer trials.
Topics Covered: Medical Imaging
Calyx Demo’s in 15 minutes
Watch a quick demo of Calyx product on demand
Improve Neuro-Psychiatric Trial Outcomes: Objective Measures for Neuro-Psychiatric Diseases
The current lack of objective biomarkers presents a real challenge for researchers developing treatments for psychiatric and neurological diseases. But now, a partnership that combines Calyx’s clinical trial imaging expertise and Ceretype’s novel functional MRI (fMRI) platform enables trial sponsors to overcome this challenge and see the physical action of a drug on patients with psychiatric and other neurological disorders.
Topics Covered: Medical Imaging
Tackling the Uncertainties of Adjuvant HCC Clinical Trial Imaging
This session will focus on the difficulty of evaluating HCC patient scans after local intervention and how sponsors can overcome the complexities associated with imaging in HCC clinical trials.
Topics Covered: Medical Imaging
Effective RTSM in Oncology Trials: Managing Sourcing Changes with Advanced IRT
In this webinar, Calyx’s Peter Tarbox shares the RTSM factors oncology trial sponsors should consider in their IRT design, focusing on how advanced IRT systems can accommodate changes in centrally and locally sourced medication for optimal clinical trial supply management.
Topics Covered: IRT
Minimize Clinical Trial Unblinding Risks: Focus on Data
In this webinar, Calyx’s Malcolm Morrissey and Maarit Kelvin Korpos review other scenarios of how study data can lead to unintentional unblinding and the processes sponsors and their IRT solution providers should follow to mitigate these risks.
Topics Covered: IRT
Experience Calyx MI in 15 Minutes
Get a glimpse into what it’s like to work with Calyx Medical Imaging and how our professional client delivery teams deliver optimal imaging solutions that meet your study needs.
Topics Covered: Medical Imaging
Improving Alzheimer’s Trial Success Through AI
This scientific discussion will review how emerging AI solutions that employ quantitative neuroimaging can help address some of the key challenges faced in Alzheimer’s Disease.
Topics Covered: Medical Imaging
Minimize Clinical Trial Unblinding Risks: Focus on Randomization
In this webinar, Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey shares his experience on how to identify the randomization implementation options that can lead to unblinding of the block size and other potential risks that could result in selection bias at the site.
Topics Covered: IRT
If You Only Knew – Calyx IRT
Learn how the functions and features of Calyx IRT get the right treatment to the right patient at the right time, regardless of how complex your RTSM needs are.
Topics Covered: IRT
Solid Tumor Trials: Maintain More Patients with irRECIST Webinar
In this webinar, Dr. Oliver Bohnsack of Calyx – a leading expert on RECIST and irRECIST – discusses the implications of these findings, what it means for oncology clinical development and treatment decision-making, and why irRECIST easily can and shall replace outdated RECIST 1.1 on all solid tumor trials going forward.
Topics Covered: IRT
Developing a Direct to Patient Shipment Strategy
DTP Series Part 1
A panel of clinical trial sponsor and distribution partner representatives – all with experience in direct-to-patient shipments – will review what is possible to achieve and what constraints may be encountered when considering DtP for clinical trials. We’ll also hear from the most important clinical trial stakeholder, a patient who has experienced the shift from in-clinic visits to treatment delivered at their doorstep; he will share his perspective as it relates to the development of a DtP clinical trial strategy.
Topics Covered: DtP
The Practicality of Direct to Patient Shipments for Sites and Patients
DTP Series Part 2
Topics Covered: DtP
Imaging Biomarkers in Early Phase Oncology Trials: Choosing the Right Strategy
Topics Covered: Medical Imaging
Myeloma Trials: The Changing landscape of Imaging in IMWG Response Assessment
In this live virtual event, a panel of key opinion leaders including IMWG 2016 authors and imaging experts will answer your questions about the changing landscape of imaging in multiple myeloma trials and how to optimize imaging-related assessments.
Topics Covered: Medical Imaging
Reducing Drug Waste through IRT
In this webinar we review how, by applying advanced IRT settings to control the supply chain, medication can be directed to recruiting sites only and amounts shipped to those sites can be reduced to the minimum, overall limiting the quantity of medication wasted at site.
Topics Covered: IRT
Unintentional Unblinding: Don’t Miss Hidden Risks
Join Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey, for a webinar focusing on an undervalued aspect of study and IRT design.
Topics Covered: IRT
Tackling Trial Supply Shortages with Advanced IRT
Medication supply shortages have become a widespread industry concern. However, a considered RTSM design can prevent shortages from jeopardizing your study goals.
Topics Covered: IRT
Assessing Prostate Cancer Treatment Response Using PSMA PET/CT
In this webinar, Professor Fendler from the University of Essen and Calyx’s Dr. Oliver Bohnsack will address these challenges and provide recommendations on how to overcome them based on their own lessons learned from conducting prostate cancer trials.
Topics Covered: Medical Imaging
Improve Neuro-Psychiatric Trial Outcomes: Objective Measures for Neuro-Psychiatric Diseases
The current lack of objective biomarkers presents a real challenge for researchers developing treatments for psychiatric and neurological diseases. But now, a partnership that combines Calyx’s clinical trial imaging expertise and Ceretype’s novel functional MRI (fMRI) platform enables trial sponsors to overcome this challenge and see the physical action of a drug on patients with psychiatric and other neurological disorders.
Topics Covered: Medical Imaging
Tackling the Uncertainties of Adjuvant HCC Clinical Trial Imaging
This session will focus on the difficulty of evaluating HCC patient scans after local intervention and how sponsors can overcome the complexities associated with imaging in HCC clinical trials.
Topics Covered: Medical Imaging
Effective RTSM in Oncology Trials: Managing Sourcing Changes with Advanced IRT
In this webinar, Calyx’s Peter Tarbox shares the RTSM factors oncology trial sponsors should consider in their IRT design, focusing on how advanced IRT systems can accommodate changes in centrally and locally sourced medication for optimal clinical trial supply management.
Topics Covered: IRT
Minimize Clinical Trial Unblinding Risks: Focus on Data
In this webinar, Calyx’s Malcolm Morrissey and Maarit Kelvin Korpos review other scenarios of how study data can lead to unintentional unblinding and the processes sponsors and their IRT solution providers should follow to mitigate these risks.
Topics Covered: IRT
Experience Calyx IRT in 15 Minutes
Get a glimpse into what it’s like to work with Calyx IRT and how we customize our configurable core IRT system to meet your specific study needs.
Topics Covered: IRT
Improving Alzheimer’s Trial Success Through AI
This scientific discussion will review how emerging AI solutions that employ quantitative neuroimaging can help address some of the key challenges faced in Alzheimer’s Disease.
Topics Covered: Medical Imaging
Minimize Clinical Trial Unblinding Risks: Focus on Randomization
In this webinar, Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey shares his experience on how to identify the randomization implementation options that can lead to unblinding of the block size and other potential risks that could result in selection bias at the site.
Topics Covered: IRT
Solid Tumor Trials: Maintain More Patients with irRECIST Webinar
In this webinar, Dr. Oliver Bohnsack of Calyx – a leading expert on RECIST and irRECIST – discusses the implications of these findings, what it means for oncology clinical development and treatment decision-making, and why irRECIST easily can and shall replace outdated RECIST 1.1 on all solid tumor trials going forward.
Topics Covered: IRT
Developing a Direct to Patient Shipment Strategy
DTP Series Part 1
A panel of clinical trial sponsor and distribution partner representatives – all with experience in direct-to-patient shipments – will review what is possible to achieve and what constraints may be encountered when considering DtP for clinical trials. We’ll also hear from the most important clinical trial stakeholder, a patient who has experienced the shift from in-clinic visits to treatment delivered at their doorstep; he will share his perspective as it relates to the development of a DtP clinical trial strategy.
Topics Covered: DtP
The Practicality of Direct to Patient Shipments for Sites and Patients
DTP Series Part 2
Topics Covered: DtP
Imaging Biomarkers in Early Phase Oncology Trials: Choosing the Right Strategy
Topics Covered: Medical Imaging
Myeloma Trials: The Changing landscape of Imaging in IMWG Response Assessment
In this live virtual event, a panel of key opinion leaders including IMWG 2016 authors and imaging experts will answer your questions about the changing landscape of imaging in multiple myeloma trials and how to optimize imaging-related assessments.
Topics Covered: Medical Imaging
Reducing Drug Waste through IRT
In this webinar we review how, by applying advanced IRT settings to control the supply chain, medication can be directed to recruiting sites only and amounts shipped to those sites can be reduced to the minimum, overall limiting the quantity of medication wasted at site.
Topics Covered: IRT
Unintentional Unblinding: Don’t Miss Hidden Risks
Join Calyx’s Head of Statistics and Product Support Services, Malcolm Morrissey, for a webinar focusing on an undervalued aspect of study and IRT design.
Topics Covered: IRT
